The Role of Hypoxia and the Immune System in Tumor Radioresistance

The Role of Hypoxia and the Immune System in Tumor Radioresistance

Radiotherapy is given to a majority of patients with cancer, and remains one of the most (cost)effective treatment options available [...]

Bibliographic Details
Main Authors:	Paul N. Span, Jan Bussink
Format:	Article
Language:	English
Published:	MDPI AG 2019-10-01
Series:	Cancers
Subjects:	n/a
Online Access:	https://www.mdpi.com/2072-6694/11/10/1555

Similar Items

MODERN CONCEPTS ON THE ROLE OF HYPOXIA IN THE DEVELOPMENT OF TUMOR RADIORESISTANCE
by: M. A. Senchukova, et al.
Published: (2020-12-01)

Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity
by: Daan F Boreel, et al.
Published: (2021-03-01)

Critical Role of Aberrant Angiogenesis in the Development of Tumor Hypoxia and Associated Radioresistance
by: Gabriele Multhoff, et al.
Published: (2014-04-01)

The Role of Hypoxia and SRC Tyrosine Kinase in Glioblastoma Invasiveness and Radioresistance
by: Filippo Torrisi, et al.
Published: (2020-10-01)

Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models
by: Fokko J. Huizing, et al.
Published: (2021-07-01)

Plant Responses to Hypoxia: Signaling and Adaptation
by: Elena Loreti, et al.
Published: (2020-12-01)

Editorial to Radiation in Multimodal Tumor Immune Therapies—Mechanisms and Application
by: Benjamin Frey, et al.
Published: (2021-07-01)

Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing
by: Alexander E. Kabakov, et al.
Published: (2021-03-01)

The role of HIF-1α in chemo-/radioresistant tumors
by: Xia Y, et al.
Published: (2018-05-01)

Hypoxia-induced autophagy as an additional mechanism in human osteosarcoma radioresistance
by: Helin Feng, et al.
Published: (2016-06-01)

Tumors of the Central Nervous System: An Update
by: Carla Mucignat-Caretta
Published: (2020-09-01)

Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines
by: Eva-Leonne Göttgens, et al.
Published: (2021-03-01)

The Role of MicroRNAs in Tumor Growth and Radioresistance of Atypical Teratoid/rhabdoid Tumor (ATRT)
by: Yi-Yen Lee, et al.
Published: (2015)

The Effect of Autophagy on the Radioresistance  of Human Adenocarcinoma A549 Cell in Hypoxia Condition
by: Yong LI, et al.
Published: (2012-11-01)

Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck
by: Stegeman Hanneke, et al.
Published: (2012-10-01)

RADIORESISTANCE OF THE TUMOR AND ITS SOLUTIONS (LITERATURE REVIEW)
by: Yu. A. Barsukov, et al.
Published: (2015-05-01)

NEUTRON THERAPY IN THE TREATMENT OF RADIORESISTANT MALIGNANT TUMORS
by: L. I. Musabaeva, et al.
Published: (2016-07-01)

Role of Stromal Cells in Determining Tumor and Cancer Stem Cell Behaviors and Therapeutic Response
by: Stephan J. Reshkin, et al.
Published: (2020-10-01)

Editorial On “Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy”
by: Vita Golubovskaya, et al.
Published: (2020-07-01)

Micronutrients and the Immune System: Some Is Good but We Need to Know More
by: Henry J. Thompson
Published: (2021-01-01)

Special Issue “IFN-Independent ISG Expression and Its Role in Antiviral Cell-Intrinsic Innate Immunity”
by: Emmanuel Thomas, et al.
Published: (2019-10-01)

Radioresistant laryngeal cancer
by: Nix, Paul Alan
Published: (2004)

Nutraceuticals in Immune Function
by: Soo-Liang Ooi, et al.
Published: (2021-09-01)

The Interplay Between Antioxidants and the Immune System: A Promising Field, Still Looking for Answers
by: Giulio Francesco Romiti, et al.
Published: (2020-05-01)

MODERN RADIOTHERAPY REGIMENS AND BIOMARKERS OF RADIORESISTANT RECTAL TUMOR CELLS
by: N. G. Vasilchenko, et al.
Published: (2020-01-01)

Potential Molecular Players of the Tumor Microenvironment in Extracranial Pediatric Solid Tumors
by: Rosa Noguera, et al.
Published: (2020-10-01)

Immune Therapies for Hematologic Malignancies
by: Matthew J. Olnes
Published: (2021-01-01)

Tumor Microenvironment and Metabolism
by: Li V. Yang
Published: (2017-12-01)

Involvement of Decreased Hypoxia-Inducible Factor 1 Activity and Resultant G1-S Cell Cycle Transition in Radioresistance of Perinecrotic Tumor Cells
by: Zhu, Yuxi
Published: (2012)

Circulating miRNAs as Tumor Biomarkers: A Preface to the Special Issue
by: Athina N. Markou
Published: (2020-12-01)

Special Issue: Immune Dysfunction in Uremia
by: Gerald Cohen, et al.
Published: (2021-01-01)

Targeting Innate Immunity to Treat Cancer
by: Matthew Austin, et al.
Published: (2020-09-01)

Immune Responses to Nanomaterials for Biomedical Applications
by: Giuseppe Bardi
Published: (2021-05-01)

The Tumor Microenvironment of Pancreatic Cancer
by: Eva Karamitopoulou
Published: (2020-10-01)

The Importance of Tumor–Host Interactions in Adult B-Cell Leukemias and Lymphomas
by: Silvia Deaglio, et al.
Published: (2020-09-01)

Comparative Studies on the Human Serum Albumin Binding of the Investigational EGFR Inhibitor KP2187, Its Hypoxia-Activated Cobalt Complex, and a Series of Clinically Approved Inhibitors
by: Eva Anna Enyedy, et al.
Published: (2019-08-01)

Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene Assay
by: Michael A. Jacobs, et al.
Published: (2020-09-01)

ALDH-1-positive cells exhibited a radioresistant phenotype that was enhanced with hypoxia in cervical cancer
by: Tingting Yao, et al.
Published: (2020-09-01)

Why Target Innate Immune Cells in Cancers?
by: Mary Poupot
Published: (2021-02-01)

Cholesterol and Inflammation in Atherosclerosis: An Immune-Metabolic Hypothesis
by: Didac Mauricio, et al.
Published: (2020-08-01)